{"id":"placebo-weeks-48-72","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Placebo is an inert substance administered in blinded clinical trials to establish baseline disease progression and distinguish true drug efficacy from natural disease course or psychological expectation effects. In this Phase 3 trial context (weeks 48-72), placebo recipients receive no active therapeutic intervention, allowing researchers to measure the true clinical benefit of the investigational agent being tested.","oneSentence":"Placebo produces no pharmacological effect and serves as a control comparator in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:54.169Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06732245","phase":"PHASE2","title":"Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese","status":"NOT_YET_RECRUITING","sponsor":"Biomed Industries, Inc.","startDate":"2026-08-15","conditions":"Obesity and Overweight","enrollment":224},{"nctId":"NCT04378075","phase":"PHASE2, PHASE3","title":"A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy","status":"TERMINATED","sponsor":"PTC Therapeutics","startDate":"2020-09-28","conditions":"Mitochondrial Diseases, Drug Resistant Epilepsy, Leigh Disease","enrollment":68},{"nctId":"NCT04192136","phase":"NA","title":"NAD+ and Exercise in FA","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-09-03","conditions":"Friedreich Ataxia 1","enrollment":75},{"nctId":"NCT05104476","phase":"PHASE2","title":"A Study of Lu AF82422 in Participants With Multiple System Atrophy","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lundbeck A/S","startDate":"2021-11-16","conditions":"Multiple System Atrophy","enrollment":64},{"nctId":"NCT01651403","phase":"PHASE3","title":"Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2012-12-06","conditions":"Chronic Hepatitis B","enrollment":90},{"nctId":"NCT05598112","phase":"EARLY_PHASE1","title":"Effect of Gut Microbiome Intervention on Aging Via Oral FMT","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2023-04-24","conditions":"Aging, Frailty","enrollment":210},{"nctId":"NCT05194397","phase":"PHASE2","title":"Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-02-23","conditions":"Lymphoblastic Leukemia, Cancer Survivors, Aplastic Anemia","enrollment":80},{"nctId":"NCT06706310","phase":"PHASE2","title":"Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-12-04","conditions":"Chronic Hepatitis B","enrollment":116},{"nctId":"NCT03945292","phase":"PHASE2","title":"Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2019-08-07","conditions":"Alpha 1-Antitrypsin Deficiency","enrollment":40},{"nctId":"NCT05824871","phase":"PHASE3","title":"A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients","status":"RECRUITING","sponsor":"Shanghai Jiatan Pharmatech Co., Ltd","startDate":"2022-09-02","conditions":"Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)","enrollment":450},{"nctId":"NCT02935686","phase":"PHASE1, PHASE2","title":"A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults","status":"COMPLETED","sponsor":"Janssen Vaccines & Prevention B.V.","startDate":"2017-03-31","conditions":"Healthy","enrollment":155},{"nctId":"NCT02788045","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults","status":"COMPLETED","sponsor":"Janssen Vaccines & Prevention B.V.","startDate":"2016-07-08","conditions":"Healthy","enrollment":201},{"nctId":"NCT03580356","phase":"PHASE3","title":"A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-10-20","conditions":"Chronic Spontaneous Urticaria","enrollment":1078},{"nctId":"NCT06544551","phase":"PHASE3","title":"Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Beijing Kawin Technology Share-Holding Co., Ltd.","startDate":"2021-12-28","conditions":"Chronic Hepatitis B Virus Infection","enrollment":336},{"nctId":"NCT05584384","phase":"NA","title":"The Use of tDCS in the Orofacial Pain","status":"UNKNOWN","sponsor":"Charles University, Czech Republic","startDate":"2022-10-03","conditions":"Orofacial Pain","enrollment":40},{"nctId":"NCT03580369","phase":"PHASE3","title":"A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-10-17","conditions":"Chronic Spontaneous Urticaria","enrollment":1072},{"nctId":"NCT05744752","phase":"NA","title":"Effects of Allium Sativum and Moringa Oleifera Extract on Dental Enamel","status":"UNKNOWN","sponsor":"Arslan Saleem","startDate":"2022-12-19","conditions":"Lead Poisoning","enrollment":90},{"nctId":"NCT02727907","phase":"PHASE2, PHASE3","title":"Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis","status":"COMPLETED","sponsor":"Biocad","startDate":"2015-02-12","conditions":"Multiple Sclerosis","enrollment":163},{"nctId":"NCT03802630","phase":"PHASE3","title":"Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-07-02","conditions":"Branch Retinal Vein Occlusion","enrollment":450},{"nctId":"NCT03810313","phase":"PHASE3","title":"Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-07-03","conditions":"Central Retinal Vein Occlusion","enrollment":493},{"nctId":"NCT03158285","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-07-12","conditions":"Arthritis, Psoriatic","enrollment":741},{"nctId":"NCT03131570","phase":"PHASE2","title":"Safety and Efficacy of Secukinumab in Mild Psoriasis","status":"COMPLETED","sponsor":"James G. Krueger, MD, PhD","startDate":"2017-05-23","conditions":"Psoriasis","enrollment":23},{"nctId":"NCT05437185","phase":"NA","title":"Long-term tDCS Tinnitus Treatment","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2019-09-01","conditions":"Tinnitus","enrollment":44},{"nctId":"NCT00045968","phase":"PHASE3","title":"Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer","status":"UNKNOWN","sponsor":"Northwest Biotherapeutics","startDate":"2006-12","conditions":"Glioblastoma Multiforme, Glioblastoma, GBM","enrollment":348},{"nctId":"NCT02568215","phase":"PHASE2","title":"Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-05","conditions":"HIV Infections","enrollment":1924},{"nctId":"NCT02716675","phase":"PHASE2","title":"Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-04-06","conditions":"HIV Infections","enrollment":2699},{"nctId":"NCT00761657","phase":"PHASE2","title":"Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis","status":"COMPLETED","sponsor":"Kyntra Bio","startDate":"2006-11-01","conditions":"Chronic Kidney Disease, Anemia","enrollment":117},{"nctId":"NCT03170271","phase":"PHASE3","title":"A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-07-07","conditions":"Asthma","enrollment":660},{"nctId":"NCT03594656","phase":"PHASE3","title":"Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2018-07-15","conditions":"Parkinson Disease","enrollment":288},{"nctId":"NCT01944046","phase":"PHASE2","title":"Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors","status":"COMPLETED","sponsor":"Linmarie Sikich","startDate":"2014-08-01","conditions":"Autism Spectrum Disorders","enrollment":290},{"nctId":"NCT03019796","phase":"EARLY_PHASE1","title":"Exercise Training Effects on Metabolic Syndrome: Interactions With Medication","status":"COMPLETED","sponsor":"University of Castilla-La Mancha","startDate":"2015-07","conditions":"Exercise Therapy, Metabolic Syndrome X, Cardiorespiratory Fitness","enrollment":40},{"nctId":"NCT01958476","phase":"PHASE3","title":"Improving Outcomes in Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2013-09","conditions":"Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal","enrollment":117},{"nctId":"NCT01661140","phase":"PHASE4","title":"A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2012-09","conditions":"Rheumatoid Arthritis","enrollment":427},{"nctId":"NCT00409591","phase":"PHASE3","title":"Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand","status":"TERMINATED","sponsor":"Institut de Recherche pour le Developpement","startDate":"2008-07","conditions":"HIV Infections, Pregnancy","enrollment":435},{"nctId":"NCT01186289","phase":"NA","title":"Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2010-10","conditions":"Neurocognitive Dysfunction","enrollment":""},{"nctId":"NCT01004432","phase":"PHASE3","title":"Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)","status":"COMPLETED","sponsor":"Janssen Biotech, Inc.","startDate":"2009-12","conditions":"Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases","enrollment":433},{"nctId":"NCT02392988","phase":"NA","title":"Does Acupuncture Therapy Reduce the Need for Labor Induction After Postdate (Week 41)","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2015-05","conditions":"Post-term Pregnancy (40 to 42 Weeks Gestation)","enrollment":600},{"nctId":"NCT01956760","phase":"NA","title":"Effects of Acupuncture and Intradermal Acupuncture on Insomnia","status":"UNKNOWN","sponsor":"Kyunghee University","startDate":"2012-09","conditions":"Insomnia","enrollment":38},{"nctId":"NCT01386333","phase":"PHASE1","title":"Safety Study of Intranasal Oxytocin in Frontotemporal Dementia","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2011-06","conditions":"Frontotemporal Dementia","enrollment":23},{"nctId":"NCT00722098","phase":"PHASE2","title":"Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients","status":"TERMINATED","sponsor":"Baylor Research Institute","startDate":"2008-06","conditions":"Malignant Melanoma Stage IV","enrollment":9},{"nctId":"NCT00603304","phase":"PHASE3","title":"Complementary and Alternative Medicine for Urological Symptoms(CAMUS)","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2008-02","conditions":"Urological","enrollment":369}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":19,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo - weeks 48 - 72","genericName":"Placebo - weeks 48 - 72","companyName":"University of Alabama at Birmingham","companyId":"university-of-alabama-at-birmingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo was used in clinical trials for various conditions, including HIV Infections, Pregnancy, Autism Spectrum Disorders, Frontotemporal Dementia, and Rifampin-Resistant Pulmonary Tuberculosis. Specifically, Placebo was used as a maternal intervention in combination with infant nevirapine in a study on HIV Infections and Pregnancy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}